3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
59
Breast Neoplasms
52
Ovarian Neoplasms
34
Triple Negative Breast Neoplasms
28
Lung Neoplasms
25
Fallopian Tube Neoplasms
24
Endometrial Neoplasms
23
Neoplasm Metastasis
20
Parkinson Disease 4, Autosomal Dominant Lewy Body
19
Squamous Cell Carcinoma of Head and Neck
18
Neoplasms
15
Esophageal Squamous Cell Carcinoma
11
Esophageal Neoplasms
11
Head and Neck Neoplasms
10
Carcinoma, Ovarian Epithelial
10
Stomach Neoplasms
9
Carcinoma
9
Colorectal Neoplasms
7
Adenocarcinoma
7
Adenocarcinoma Of Esophagus
6
Uterine Cervical Neoplasms
5
Peritoneal Neoplasms
5
Melanoma
5
Small Cell Lung Carcinoma
4
Oropharyngeal Neoplasms
4
Carcinoma, Transitional Cell
4
Urinary Bladder Neoplasms
3
Respiratory Tract Neoplasms
3
Recurrence
3
Pancreatic Neoplasms
3
Interventions
Magnetic Resonance Spectroscopy
56
enzalutamide
44
Specimen Handling
37
apalutamide
35
Androgen Antagonists
35
Abiraterone Acetate
29
Prednisone
27
Radiosurgery
26
darolutamide
25
Docetaxel
23
Pluvicto
22
abiraterone
21
Radiotherapy
21
Leuprolide
20
Biopsy
16
relugolix
14
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
14
gallium 68 PSMA-11
12
Triptorelin Pamoate
12
Surveys and Questionnaires
12
Radiation
12
Gonadotropin-Releasing Hormone
12
X-Rays
11
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
10
cabazitaxel
9
bicalutamide
9
Standard of Care
9
Nivolumab
9
Goserelin
9
Carboplatin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Paclitaxel
×
90 days
×
Clear all
No trials found.